Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

by Arnold, Melina, PhD, Rutherford, Mark J, PhD, Bardot, Aude, MSc, Ferlay, Jacques, ME, Andersson, Therese M-L, PhD, Myklebust, Tor Åge, PhD, Tervonen, Hanna, PhD, Thursfield, Vicky, Grad Dip, Ransom, David, MD, Shack, Lorraine, PhD, Woods, Ryan R, PhD, Turner, Donna, PhD, Leonfellner, Suzanne, BN, Ryan, Susan, CTR, Saint-Jacques, Nathalie, PhD, De, Prithwish, PhD, McClure, Carol, PhD, Ramanakumar, Agnihotram V, PhD, Stuart-Panko, Heather, CHIM, Engholm, Gerda, MSc, Walsh, Paul M, PhD, Jackson, Christopher, FRACP, Vernon, Sally, MMath, Morgan, Eileen, PhD, Gavin, Anna, FFPHM, Morrison, David S, Prof, Huws, Dyfed W, MSc, Porter, Geoff, MD, Butler, John, MRCOG, Bryant, Heather, PhD, Currow, David C, Prof, Hiom, Sara, BSc, Parkin, D Max, DSc, Sasieni, Peter, Prof, Lambert, Paul C, Prof, Møller, Bjørn, PhD, Soerjomataram, Isabelle, PhD, Bray, Freddie, PhD
Published in The lancet oncology

Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial

by Laursen, Jens Christian, Søndergaard-Heinrich, Niels, de Melo, Joana Mendes Lopes, Haddock, Bryan, Rasmussen, Ida Kirstine Bull, Safavimanesh, Farzaneh, Hansen, Christian Stevns, Størling, Joachim, Larsson, Henrik Bo Wiberg, Groop, Per-Henrik, Frimodt-Møller, Marie, Andersen, Ulrik Bjørn, Rossing, Peter
Published in EClinicalMedicine